RNAimmune Competitors and Similar CompaniesClear all
Uvax Bio's competitors and similar companies include CureVac and RNACure.
 Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. |  RNACure RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis. | ||
Founding Date | Founding Date 2018 | Founding Date 2000 | Founding Date 2019 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Wilmington, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Shanghai, CN HQ |
Employees | Employees 1110% increase | Employees 82517% decrease | Employees 5 |
Operating ⚠ | |||
Patents Issued | Patents Issued 1 (May, 2020) | Patents Issued 233 (May, 2020) | Patents Issued N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyRNACure
HQ
Shanghai, CN
Employees
5
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
View company